Verition Fund Management LLC Akebia Therapeutics, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.87 - $1.84 $48,606 - $102,800
55,870 New
55,870 $63,000
Q2 2022

Aug 15, 2022
BUY
$0.32 - $0.67 $3,415 - $7,150
10,673 New
10,673 $4,000
Q2 2018

Aug 15, 2018
SELL
$9.15 - $11.34 $125,711 - $155,800
-13,739 Closed
0 $0
Q1 2018

May 16, 2018
BUY
$9.53 - $15.68 $130,932 - $215,427
13,739 New
13,739 $131,000

Others Institutions Holding AKBA

# of Institutions
120
Shares Held
54.9M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $417M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email